Drug factory · FDA FEI 3003015655
Lianyungang Runzhong Pharmaceutical Co., Ltd.
No. 16 Jinqiao Rd., Dapu Industrial Park, Economic Technology Development Zone, Lianyungang, China
No problems found at FDA's last inspection, Jan 26, 2024.
No Action Indicated: inspectors found no objectionable conditions.
4 drug inspections on record since 2011: 3 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Aprepitant | Makes the active ingredient | Spes Pharmaceuticals Inc. | 82243-1001 |
| Eribulin | Makes the active ingredient | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 71731-4171 |
| Fulvestrant | Makes the active ingredient | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 71731-6121 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jan 26, 2024 | No problems found | Drug Quality Assurance | — |
| Oct 26, 2018 | No problems found | Drug Quality Assurance | — |
| Mar 27, 2014 | No problems found | Drug Quality Assurance | — |
| Jul 28, 2011 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: api manufacture.